Jordan L.. Geller, MD

Primary Specialties:
  • Internal Medicine
  • Endocrinology
  • About

    About

    Physician Bio

    Dr. Jordan Geller is a native of Los Angeles. He earned his medical degree from the University of Southern California and completed a postdoctoral fellowship at Cedars-Sinai Medical Center in Los Angeles as well as an NIH fellowship in Clinical Research. He was the past Clinical Chief of the Division of Endocrinology, Diabetes & Metabolism at Cedars-Sinai Medical Center. Dr. Geller has lectured at national symposia and authored publications in the field of Endocrinology in prestigous journals including Nature, Endocrine Practice, JAMA and Endocrine Pathology.

    Dr. Geller is dual board-certified in Endocrinology, Diabetes and Metabolism and Internal Medicine and licensed in California and Florida. His private practice caters to clients who are invested in their health and well-being. Common conditions he manages include thyroid disorders, diabetes, prediabetes, hormone replacement, weight management, cholesterol disorders and osteoporosis. In addtion to Western medicine, Dr. Geller incorporates lifestyle changes and functional medicine approaches to the care of his patients whenever possible.

    Areas of Interest

    Thyroid disorders, diabetes, prediabetes, hormone replacement, weight management, cholesterol disorders and osteoporosis.

  • Education

    Education

    Medical School:

    University of Southern California Keck School of Medicine, Los Angeles

    Residency:

    Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles

    Fellowship:

    Cedars-Sinai Medical Center, Los Angeles

    Board Certification:

    Endocrinology, Diabetes and Metabolism Internal Medicine Diplomat of the American Board of Internal Medicine Diplomat of the American Board of Endocrinology, Diabetes and Metabolism

    Awards

    American Thyroid Association Fellow’s Track Recipient, Baltimore, 2005
    California Medical Assoc. Legislative Seminar grant recipient, Sacramento, 2001
    Pathology Honors Program, University of Health Sciences, 1999
    American Pediatric Society Research Fellowship 1998
    Rutger’s University Fellowship Advanced School of Alcohol and Drug Studies, 1998
    Leichtling Oncology Research Award (deferred), 1998
    Illinois Academy of Family Physicians Externship, 1998
    Summer Research Fellow, Univ. Health Sciences, 1997
    Cum Laude Honors, Loyola Marymount University, 1993
    Outstanding Graduate in Department of Sociology, Loyola Marymount Univ 2003
    Presenter, Santa Clara University Sociology Research Conference, 1993, 1994
    Dean’s List, Santa Monica College, 1989

  • Research & Publications

    Research & Publications

    Liu NA, Sacks W and Geller JL, Geller Epocrates Osteoporosis Curriculum 2010;
    Epocrates, Inc.
    Geller JL, Adams JS. Vitamin D Therapy. Current Osteoporosis Reports 2008
    Cooper OB, Geller JL and Melmed S. Ovarian Hyperstimulation Syndrome caused
    by an FSH-Secreting Pituitary Adenoma. Nat Clin Pract Endocrinol Metab. Feb 12,
    2008
    Geller JL, Hu B, Reed S, Mirocha J and Adams JS. Repair of Vitamin D Insufficiency
    Increases Bone Mass in Bisphosphonate-Treated Patients. Endo Prac. 2008; 14:3
    Geller JL Vitamin D: The Sunshine Hormone. Food Technology, June 2007
    Geller JL, Adams, JS. Proton Pump Inhibitor Therapy and Hip Fracture Risk. JAMA.
    2007; 297:1429
    Geller JL, Azarmindokht K, Kelly MH, et al. Clinical Vignette: Cinacalcet in the
    Management of Tumor-Induced Osteomalacia. J Bone Min Res. 2007; Mar 12
    Geller JL The Way I see it: Healthcare Reform Begins with Patient. Medical
    Economics. Dec 15, 2006
    Karakelides H, Geller JL, Schroeter AL, Chen H, Behn PS, Adams JA, Hewison M,
    Wermers RA. Vitamin D-mediated hypercalcemia in slack skin disease: further
    evidence for extra-renal expression of 25-hydroxyvitamin D-1α-hydroxylase in
    granulomatous disorders. J Bone Min Res. 2006 Sep; 1496-9
    Geller JL, Azer P, Mertens, RB, Weiss LM. Recurrent and Metastatic Pigmented
    Adrenocrotical Carcinoma:case report and review. Endocr Pathol. 2006; 17: 297-304.
    Geller JL, Braunstein GB. Dermatological Manifestations of Hypopituitarism. Clinics
    in Dermatology. 2006; 42:266-275.
    Geller JL. Borrowing Against the Bones: The Price of Eucalcemia. Nutrition and the
    M.D. 2006; 32:5
    Geller JL, Adams JS. Statins and Fracture: All Variables Accounted For? Archives of
    Internal Medicine 2006; 166:1041
    Geller JL, Arteaga V, Fan X, Yu J. A Symptomatic Prolactinoma Co-existing within a
    Rathke’s Cleft Cyst Invading Bone: Case Report and Review. The Endocrinologist
    2006;91-94.
    Publications Continued
    Geller, JL, Mertens, RB and Weiss LM. Adrenocortical Carcinoma: Many Questions
    Remain Unanswered. The Endocrinologist, 2005; 15: 309-312.
    Abreu MT, Kam LY, Vasiliauskas EA, Vora P, Adams JS, Yang H, Geller JL, Hu B, Lin
    YC, Keenan G, Price J, Landers CJ, Targan SR. Treatment with Infliximab is
    Associated With Increased Markers of Bone Formation in Patients With Crohn's
    Disease. Journal of Clinical Gastroenterology, 2006; 40:55-63.
    Geller JL, Hackner D. Prolonged Refractory Streptococcal Toxic Shock Syndrome
    Complicoemboli: Case Report and Review. Annals of Hematology. 2005 Apr 7
    Bhushan V, Pall V, Le T, Yen YM, Geller JL, Gupta S. Clinical Science Color Atlas.
    Blackwell, 2002
    Abstracts
    Geller JL, Reed, S, Mirocha J, Adams JS. Vitamin D Insufficiency and
    Unresponsiveness to Bisphosphonates. Cleveland Clinic Bone Innovation Summit,
    May 5, 2006.
    JL. Geller, C. Cutler, M. H. Kelly, J. S. Adams, M. T. Collins. Cinacalcet Is Associated
    with Decreased Serum FGF-23 and Improved Phosphorous Homeostasis in
    Patients with Tumor-Induced Osteomalacia. The 27th Annual Meeting of the
    American Society for Bone and Mineral Research, Nashville, Tennessee, 2005.
    Wermers RA, Karakelides H, Adams JS, Chen H, Geller JL, Hewison M. Vitamin
    D-Mediated Hypercalcemia in Granulomatous Slack Skin Disease: Evidence for the
    Extra-renal 1-Hydroxylation of 25-hydroxvitamin D in Involved Skin Granulomata.
    Endocrine Society 87th Annual Meeting, San Diego, 2005
    Geller JL, Azer P, Mertens, RB, Weiss LM. Recurrent and Metastatic Pigmented
    Adrenocortical Carcinoma. Endocrine Society 87th Annual Meeting, San Diego,
    2005
    Abreu MT, Kam LY, Vasiliauskas EA, Vora P, Adams JS, Yang H, Geller JL, et al.
    Treatment with Infliximab is Associated With Increased Markers of Bone Formation
    in Patients With Crohn's Disease. American Society for Bone and Mineral Research,
    26th Annual Meeting, Seattle, WA, 2004